Event Type
Disclosure
Mandatory
Variant
8-K
, the Company and Zynext Ventures USA LLC (“Zynext”), a wholly-owned subsidiary of ZyNext Ventures PTE. LTD Singapore, a wholly-owned subsidiary of Zydus Lifesc
Unregistered Sales of Equity Securities. As previously disclosed, on June 3, 2025, and in connection with the execution of the Purchase Agreement referred to in
to this Current Report on Form 8-K, and in Exhibit 99.1 furnished herewith, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Excha
Financial Statements and Exhibits. (b) Pro Forma Financial Information The following financial information is included as Exhibit 99.2 to this Current Report on